Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Sadif Analytics (Premium)
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IGI Laboratories Inc Receives Formal US FDA Approval For Site Transfer Of Econazole Nitrate


Friday, 1 Nov 2013 08:10am EDT 

IGI Laboratories, Inc announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of econazole nitrate cream 1%, to the company's manufacturing facility in Buena, NJ. IGI had purchased econazole nitrate cream 1% from Prasco, LLC in February of 2013. 

Company Quote

6.22
-0.12 -1.89%
26 Aug 2014